The ALS Association and NuvoAir Partner to Launch First-Ever Virtual Pulmonary Care for ALS patients

Boston, MA, December 5th, 2023 – The ALS Association, the largest philanthropic funder of ALS research, and NuvoAir, the leading value-based specialty care provider for heart and lung conditions, announced their partnership to support virtual pulmonary care for people living with ALS and their caregivers. The partnership is part of the ALS Association’s plan to bring high-quality pulmonary care to all those living with ALS.

Symptoms of respiratory decline in ALS generally go unnoticed until advanced stages. Therefore, frequent monitoring and ongoing respiratory care are crucial to ensure that timely and appropriate care and treatment can be provided. NuvoAir has a vast track record of providing tech-enabled high-quality virtual care to patients with asthma, COPD, and cystic fibrosis, amongst other lung and heart diseases.

“People living with ALS deserve access to high-quality respiratory care regardless of their zip code,” said Calaneet Balas, President and CEO of the ALS Association. “We are grateful to partner with NuvoAir, the leading innovator in this space, to bring the first-ever virtual pulmonary care to the ALS community. This will expedite people getting non-invasive ventilation and hopefully reduce hospital visits and complications from respiratory decline.”

"We view this partnership as a beacon of hope for those living with ALS. Our multidisciplinary team, empowered by cutting-edge technology, can detect early infections and declines in lung health. This enables our specialists to intervene promptly, extending and enhancing the quality of life for patients,” said Lorenzo Consoli, Founder and CEO of NuvoAir, “It is an honor for NuvoAir to serve the ALS community and through this collaboration, I believe we can make a significant and meaningful difference in the lives of many."

The partnership launches with two ALS clinics in Texas, Texas Neurology and the University of Texas Health Science Center, with the imperative support of Respiratory Quality Services, a Texas-based company providing in-person respiratory therapy.

“After serving the ALS community for over a decade with non-invasive ventilation, it is apparent that interventions in pulmonary functions between clinic visits is paramount in getting patients the care they need and preventing complications from ALS,” said Keith Sanborn, owner of Respiratory Quality Services.

“We are eager to see the impact of NuvoAir’s virtual care on patients at initial sites, as we desire to make this a standard of care for all those living with ALS,” added Balas.

This partnership marks a significant leap towards ensuring equitable access to high-quality pulmonary care for ALS patients nationwide.

ABOUT ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Over the course of the disease, people lose the ability to move, to speak, and eventually, to breathe. On average, it takes about a year before a final ALS diagnosis is made. The disease is always fatal, usually within five years of diagnosis. There is no cure.

ABOUT THE ALS ASSOCIATION

The ALS Association is the largest philanthropic funder of ALS research in the world. The Association funds global research collaborations, assists people with ALS and their families through its nationwide network of care and certified clinical care centers, and advocates for better public policies for people with ALS. The ALS Association is working to make ALS a livable disease while urgently searching for new treatments and a cure. For more information about The ALS Association, visit our website at www.als.org.

ABOUT NUVOAIR

NuvoAir Medical is reinventing the operating model for managing cardiopulmonary patients. Its AI-driven MSO and patient management technology platform empowers forward-thinking specialists to deliver more personalized and proactive care, streamline practice operations, reduce administrative burdens, and grow patient panels. By collaborating with health plans, risk-bearing entities, and innovative cardiologists and pulmonologists, NuvoAir Medical has redefined how patients with complex heart and lung issues receive high-quality, efficient care. For more information, visit us at nuvoair.com.

ABOUT RESPIRATORY QUALITY SERVICES

Respiratory Quality Services (RQS) is a company of Respiratory Therapists serving adult and pediatric patients throughout Texas and Louisiana. RQS Respiratory Therapists specialize in providing home ventilation to patients with Neuromuscular Disease and other respiratory illnesses. RQS is committed to providing the best possible clinical care with the highest level of service. For more information, visit www.rqsbreathe.com.

Media Contacts

The ALS Association:

mediarelations@alsa-national.org

NuvoAir:

media@nuvoair.com